Sperm can act as vectors for HIV-1 transmission into vaginal and cervical epithelial cells.


Journal

American journal of reproductive immunology (New York, N.Y. : 1989)
ISSN: 1600-0897
Titre abrégé: Am J Reprod Immunol
Pays: Denmark
ID NLM: 8912860

Informations de publication

Date de publication:
07 2019
Historique:
received: 03 12 2018
revised: 02 03 2019
accepted: 15 04 2019
pubmed: 9 5 2019
medline: 25 8 2020
entrez: 9 5 2019
Statut: ppublish

Résumé

Sperm are the major cells in semen. Human sperm possess a number of HIV-1 gp120 binding ligands including sulfogalactosylglycerolipid (SGG). However, the mechanisms of how sperm capture HIV-1 onto their surface are unclear. Furthermore, the ability of sperm to deliver HIV-1 to vaginal/cervical epithelial cells lining the lower female reproductive tract, as a first step in HIV-1 transmission, needs to be determined. Sperm from healthy donors were incubated with dual-tropic HIV-1 Sperm were able to capture HIV-1 in a dose-dependent manner, and the capture reached a maximum within 5 minutes. Captured HIV-1, however, could be removed from sperm by Percoll-gradient centrifugation. Affinity of gp120 for SGG was substantial, implicating sperm SGG in HIV-1 capture. Sperm-associated HIV-1 could productively infect PBMCs and TZM-bl cells, and was capable of being transmitted into vaginal/cervical epithelial cells. Sperm are able to capture HIV-1, which remains infectious and is able to be transmitted into vaginal/cervical epithelial cells, a result indicating the importance of sperm in HIV transmission.

Identifiants

pubmed: 31066971
doi: 10.1111/aji.13129
doi:

Substances chimiques

Galactolipids 0
HIV Envelope Protein gp120 0
gp120 protein, Human immunodeficiency virus 1 0
sulfogalactosylglycerolipid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13129

Subventions

Organisme : CIHR
ID : HPR-85522
Pays : Canada

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Charlene D Young (CD)

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.

Suriya Tatieng (S)

Multidisciplinary Program in Biotechnology, The Graduate School, Division of Biochemistry and Biochemical Technology, Faculty of Science, Department of Chemistry, Chiang Mai University, Chiang Mai, Thailand.

Kessiri Kongmanas (K)

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.

Duriya Fongmoon (D)

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.

Brett Lomenick (B)

Pasarow Mass Spectrometry Laboratory, University of California, Los Angeles, Los Angeles, California.

Alexander J Yoon (AJ)

Pasarow Mass Spectrometry Laboratory, University of California, Los Angeles, Los Angeles, California.

Wongsakorn Kiattiburut (W)

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Immunology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Federica Compostella (F)

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milano, Italy.

Kym F Faull (KF)

Pasarow Mass Spectrometry Laboratory, University of California, Los Angeles, Los Angeles, California.

Nuttee Suree (N)

Multidisciplinary Program in Biotechnology, The Graduate School, Division of Biochemistry and Biochemical Technology, Faculty of Science, Department of Chemistry, Chiang Mai University, Chiang Mai, Thailand.

Jonathan B Angel (JB)

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Division in Infectious Diseases, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

Nongnuj Tanphaichitr (N)

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Faculty of Medicine, Department of Obstetrics & Gynecology, University of Ottawa, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH